Quadrant Capital Group LLC raised its position in Danaher Corp. (NYSE:DHR) by 0.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,799 shares of the company’s stock after buying an additional 28 shares during the period. Quadrant Capital Group LLC’s holdings in Danaher Corp. were worth $375,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of DHR. State Street Corp increased its stake in shares of Danaher Corp. by 0.6% in the first quarter. State Street Corp now owns 22,646,064 shares of the company’s stock worth $2,148,210,000 after buying an additional 129,215 shares during the period. BlackRock Fund Advisors increased its stake in shares of Danaher Corp. by 3.3% in the first quarter. BlackRock Fund Advisors now owns 6,928,859 shares of the company’s stock worth $657,272,000 after buying an additional 218,791 shares during the period. Geode Capital Management LLC increased its stake in shares of Danaher Corp. by 5.4% in the first quarter. Geode Capital Management LLC now owns 4,873,827 shares of the company’s stock worth $461,393,000 after buying an additional 249,921 shares during the period. UBS Asset Management Americas Inc. increased its stake in shares of Danaher Corp. by 11.6% in the first quarter. UBS Asset Management Americas Inc. now owns 4,068,557 shares of the company’s stock worth $385,943,000 after buying an additional 421,790 shares during the period. Finally, Findlay Park Partners LLP increased its stake in shares of Danaher Corp. by 1.0% in the first quarter. Findlay Park Partners LLP now owns 3,378,763 shares of the company’s stock worth $320,509,000 after buying an additional 34,303 shares during the period. Institutional investors own 75.74% of the company’s stock.
Danaher Corp. (NYSE:DHR) traded up 0.15% during mid-day trading on Wednesday, reaching $77.78. The company’s stock had a trading volume of 2,090,105 shares. Danaher Corp. has a one year low of $61.60 and a one year high of $82.64. The firm’s 50 day moving average is $78.95 and its 200-day moving average is $76.59. The stock has a market cap of $53.71 billion, a P/E ratio of 15.47 and a beta of 1.13.
Danaher Corp. (NYSE:DHR) last announced its earnings results on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.03. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.76 billion. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. The business’s revenue was up 16.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.08 EPS. Equities analysts expect that Danaher Corp. will post $3.56 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Wednesday, September 28th. Danaher Corp.’s dividend payout ratio is 9.94%.
DHR has been the topic of a number of research reports. JPMorgan Chase & Co. restated a “buy” rating and set a $105.00 price target on shares of Danaher Corp. in a research report on Thursday, June 30th. Citigroup Inc. raised their price target on Danaher Corp. from $102.00 to $104.00 and gave the company a “neutral” rating in a research report on Monday, June 13th. Zacks Investment Research downgraded Danaher Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, September 29th. Morgan Stanley restated a “buy” rating and set a $86.00 price target on shares of Danaher Corp. in a research report on Wednesday, August 31st. Finally, Barclays PLC restated an “overweight” rating and set a $90.00 price target on shares of Danaher Corp. in a research report on Wednesday, July 27th. Nine investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $93.98.
In other news, CFO Daniel L. Comas sold 96,446 shares of the company’s stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the sale, the chief financial officer now directly owns 215,716 shares in the company, valued at approximately $17,447,110.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the company’s stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the sale, the insider now owns 179,054 shares in the company, valued at $14,582,157.76. The disclosure for this sale can be found here. Insiders own 12.60% of the company’s stock.
About Danaher Corp.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.